Bonesupport Holding AB

BONEX

SE0009858152

Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 11:29:36 2024-05-28 EDT			5-day change	1st Jan Change
248.8 ^SEK	-3.72%		-0.88%	+32.20%

04-25	Transcript : Bonesupport Holding AB, Q1 2024 Earnings Call, Apr 25, 2024
04-25	Bonesupport Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Bonesupport Holding AB Appoints Simon Cartmell as New Board Member

July 26, 2018 at 02:00 am

BONESUPPORT HOLDING AB (publ) appointed Simon Cartmell as new Board member in its annual general meeting.

Latest news about Bonesupport Holding AB

Transcript : Bonesupport Holding AB, Q1 2024 Earnings Call, Apr 25, 2024	04-25
Bonesupport Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Nordic Shares Decreased Friday; BoneSupport Holding Posted Biggest Loss	03-15	DJ
Nordic Stocks Moved Upward Thursday; Scatec Climbed Highest	03-14	DJ
Bonesupport’s Orthopedic Medical Device for Open Fractures Gains US FDA Nod	03-14	MT
Nordic Shares Moved Upward Wednesday; BoneSupport Holding Topped Leaders	03-06	DJ
Bonesupport Holding AB Announces Resignation of Kristina Ingvar as Executive Vice President Quality Management & Regulatory Affairs	02-23	CI
Nordic Stocks Closed Up Monday; Tele2 Series a Topped Leaders	02-19	DJ
Nordic Stocks Closed Up Friday; Yubico Led Increases	02-16	DJ
Bonesupport Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-15	CI
Bonesupport Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-15	CI
Transcript : Bonesupport Holding AB, 2023 Earnings Call, Feb 15, 2024	02-15
Transcript : Bonesupport Holding AB - Analyst/Investor Day	11-28
Bonesupport Holding AB Provides Sales Guidance for the Year 2024	11-28	CI
Bonesupport Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Transcript : Bonesupport Holding AB, Nine Months 2023 Earnings Call, Oct 26, 2023	23-10-26
Bone Support Receives ?Breakthrough Device Designation? for Cerament® V for the Indication of Bone Infection	23-10-16	CI
Transcript : Bonesupport Holding AB, Q2 2023 Earnings Call, Jul 13, 2023	23-07-13
Bonesupport Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-13	CI
Bonesupport Holding AB Launches Next Generation of CeramentÂ® G	23-06-29	CI
BONESUPPORT Holding AB Announces Strong Long-Term Results with CERAMENT®G for Severe Open Fractures	23-05-25	CI
Transcript : Bonesupport Holding AB, Q1 2023 Earnings Call, Apr 27, 2023	23-04-27
Bonesupport Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Transcript : Bonesupport Holding AB, 2022 Earnings Call, Feb 16, 2023	23-02-16
Bonesupport Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-16	CI

Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.

Sector

Pharmaceuticals

Calendar

2024-07-11 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Bonesupport Holding AB

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

248.8 SEK

Average target price

292.7 SEK

Spread / Average Target

+17.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
BONESUPPORT HOLDING AB	+32.20%	1.6B
CSL LIMITED	-2.45%	90.28B
SAMSUNG BIOLOGICS CO.,LTD.	-1.97%	39.5B
BIOGEN INC.	-15.47%	31.71B
UCB	+61.28%	26.41B
BIOMARIN PHARMACEUTICAL INC.	-22.81%	14.34B
INCYTE CORPORATION	-8.82%	12.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.77%	11.8B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-45.97%	10.95B
SWEDISH ORPHAN BIOVITRUM AB	+3.30%	8.85B

Biopharmaceuticals